Japan Daily Briefing

Business Times Singapore reported that the Bank of Japan is set to raise its policy rate to 1.25%, a level unseen since 1995. The hike is priced in, but the forward guidance language on further normalisation is the real market mover. A hawkish surprise on pace would push USD/JPY below 143 and hit export names — Toyota and the five sogo shosha houses. A dovish gloss would give Nikkei 225 room to retest 40,000. TOPIX vs Nikkei 225 divergence post-announcement will be the definitive read.

Toyo Keizai Online flagged that Japanese long-term yields have breached 3% for the first time in approximately 30 years, raising concerns about debt-sustainability if the government doesn't demonstrate fiscal credibility to match the BoJ's tightening. The SCMP opinion piece on Japanese monetary policy sovereignty — questioning whether Tokyo or Washington controls BoJ decisions after the July joint FX intervention — adds another layer of uncertainty. USD/JPY management is now a shared US-Japan exercise, which caps the downside for JPY even as domestic rates rise.

Takeda Pharmaceutical (TAK) topped the leaderboard at +2.20% to $19.05, confirmed by the session data. Sumitomo Mitsui Financial Group (SMFG) added +1.64% to $26.72, consistent with the view that Japanese bank stocks benefit from a rising yield curve. The Hitachi (HTHIY) +1.92% and Kyocera (KYOCY) +1.78% moves in electronics and industrials signal that the TSE Prime Market governance reform story — buybacks, PBR<1 discipline — is still attracting value rotation capital.